Treatment of complicated colorectal cancer. Evaluation of the outcome

被引:2
|
作者
Saliangas K. [1 ,2 ]
Economou A. [1 ]
Nikoloudis N. [1 ]
Andreadis E. [1 ]
Prodromou K. [1 ]
Chrissidou M. [1 ]
Topsis D. [1 ]
Chrissidis T. [1 ]
机构
[1] Department of Surgery, General Hospital of Edessa
[2] Veria 59100
关键词
Bleeding; Complicated colorectal cancer; Obstruction; Perforation;
D O I
10.1007/s10151-004-0156-3
中图分类号
学科分类号
摘要
A comparison of the outcome of 66 patients with complicated colorectal cancer (CRC) who underwent an emergency operation and 217 electively operated patients in an 11-year period was retrospectively determined. The complications presented on admission were obstruction (13.4%), perforation with peritonitis (6.36%), obstruction and perforation (1.4%) and massive bleeding (2.1%). The majority of the patients electively treated were of stages II and III (45.5% and 29%) and those urgently operated on were stages III and IV (67.7% and 14.1%) respectively. Radical resections were performed in 45 patients and palliative in 21. Only ten patients from the urgently treated are still alive and free of the disease. In conclusion, the treatment of complicated CRC carries a considerable incidence of complications, morbidity and mortality, and the overall 5-year survival rate is disappointing compared to electively treated patients.
引用
收藏
页码:S199 / S201
页数:2
相关论文
共 50 条
  • [41] Diet, colorectal adenomas, and colorectal cancer.
    Byers, T
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (16): : 1206 - 1207
  • [42] COMPLICATED COLORECTAL-CANCER - RESULTS OF THE SURGICAL-TREATMENT
    LAZAR, F
    MICULIT, F
    DUTA, C
    MICLAUS, M
    PANTEA, S
    BORDOS, D
    BRITISH JOURNAL OF SURGERY, 1995, 82 : 28 - 28
  • [43] An evaluation of national treatment trends in pancreatic cancer.
    Seal, Brian S.
    Xia, Fang
    Germino, Rebecca
    Rietschel, Petra
    Asche, Carl V.
    D'Souza, Anna O.
    Morland, Keille
    Eaddy, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Analysis of the efficacy of CIK therapy in adjuvant treatment of colorectal cancer.
    Guo, Rui
    Piao, Haiyan
    Shi, Gang
    Zhang, Guirong
    Zhang, Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Racial differences in the pattern of hematologic toxicity in the treatment of colorectal cancer.
    Oluwole, Olalekan O.
    Wu, William
    Wolff, Steven N.
    Hande, Kenneth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [46] Tumor characteristics and treatment in early-onset colorectal cancer.
    Burnett-Hartman, Andrea
    Powers, John D.
    Chubak, Jessica
    Corley, Douglas
    Ghai, Nirupa R.
    McMullen, Carmit K.
    Pawloski, Pamala A.
    Feiglelson, Heather S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] AVIDIO as a novel oncolytic immunotherapy platform for the treatment of colorectal cancer.
    Almassian, Bijan
    Madina, Bhaskara R.
    Chen, Ju
    Ye, Xiaoyang
    Krady, Marie M.
    Ma, Xianyong
    Yarovinsky, Timur O.
    Mason, Stephen W.
    Nakaar, Valerian
    Wang, Kepeng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Complications of the colorectal cancer. Surgical treatment. 190 cases
    Troiano, L
    Blanco, A
    Giambusso, A
    Iudici, P
    Gitana, C
    EUROPEAN COUNCIL OF COLOPROCTOLOGY - ECCP BIENNIAL MEETING, 1997, : 45 - 46
  • [49] Abdominal aorta aneurysm and synchronous colorectal cancer. Changes in treatment?
    Lopez Arquillo, Irene M.
    Vidal Rey, Jorge
    Manuel Encisa de Sa, Jose
    CIRUGIA ESPANOLA, 2017, 95 (02): : 114 - 116
  • [50] Evaluation of the efficacy of chemotherapy with capecitabine and oxaliplatin in patients with disseminated colorectal cancer. The impact of primary cancer focus on treatment efficacy
    Kosakowska, Ewa Anna
    Rutkowski, Andrzej
    Wysocki, Piotr T.
    Michalski, Wojciech
    Cencelewicz-Lesikow, Anna
    Kunkiel, Michal
    Jagiello-Gruszfeld, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2021, 17 (01): : 1 - 5